Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.3.0.15
Consolidated Statements of Cash Flows (USD $)
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash flows from operating activities    
Net earnings (loss) $ (496,037) $ (494,397)
Adjustments to reconcile net earnings (loss) to net cash used in operating activities:    
Other than temporary decline in available-for-sale securities 147,973 40,386
Depreciation 7,573 8,281
Equity in (earnings) loss of investments 9,256 (42,850)
Beneficial conversion feature of convertible notes payable 0 49,994
Amortization to interest expense of value of warrants 12,588 0
Common stock issued for services 29,723 0
Investment received in exchange for management services 0 (33,000)
Realized (gains) losses from sales of investments (19,991) (149,350)
Bad debt expense 750 0
Non-controlling interest (1,376) (430)
Change in other assets and liabilities:    
(Increase) decrease in accounts receivable (62,410) (2,482)
(Increase) decrease in prepaid expenses and other assets (14,507) 2,500
Increase (decrease) in accounts payable and accrued expenses (53,054) 44,163
Advances from (repayment to) related parties (38,883) 3,174
Increase (decrease) in deferred revenue (1,750) (16,459)
Net cash used in operating activities (480,145) (590,470)
Cash flows from investing activities    
Purchase of fixed assets 0 (3,628)
Purchase of investments (877,228) (26,334)
Purchase of treasury stock 0 (680)
Proceeds from sale of treasury stock 26,401 0
Distributions from equity investments 8,140 11,833
Proceeds from sale of investments 190,325 182,710
Net cash provided by (used in) operating activities (652,362) 163,901
Cash flows from financing activities    
Proceeds from sale of common stock warrants, net 20,608 0
Loan repayment (5,251) (4,500)
Loan proceeds 1,295,000 441,000
Net cash provided by financing activities 1,310,357 436,500
Net increase (decrease) in cash and cash equivalents 177,850 9,931
Cash and cash equivalents, beginning of period 46,007 2,374
Cash and cash equivalents, end of period 223,857 12,305
Supplemental cash flow information    
Interest 85,176 20,139
Income taxes 0 0
Non-cash investing and financing activities:    
Investments received for management consulting contracts 0 33,000
Due to related party exchanged for convertible note payable 25,000 0
Convertible notes payable exchanged for common stock 711,500 0
Accrued interest exchanged for common stock 10,000 0
Common stock issued for loan from related party 0 58,790
Investment exchanged for another investment 0 124,573
Investment contributed by the Company's CEO 125,331 0
Common stock issued for prepaid consulting contract $ 44,850 $ 10,000